Small Molecules

21 Mar 2007 Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
21 Mar 2007 Cell Therapeutics Inc. (CTI) Files for Special Protocol Assessment (SPA) for XYOTAX(TM) PGT307 Lung Cancer Trial in Women
21 Mar 2007 Avexa Limited (AVX.AX) Reports Positive Phase IIb Results
21 Mar 2007 Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
21 Mar 2007 Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
20 Mar 2007 Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet Primary Endpoint
20 Mar 2007 ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
20 Mar 2007 Neuropharma presents advances in the development of NP-61 at the Alzheimer's and Parkinson's Diseases International Conference
20 Mar 2007 Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
20 Mar 2007 Akesis Pharmaceuticals Obtains Exclusive License for Proprietary Clinical Stage Diabetes Therapy from the University of British Columbia
20 Mar 2007 New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
20 Mar 2007 In new study, Duloxetine reduced non-specific pain and emotional symptoms associated with depression
20 Mar 2007 Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
20 Mar 2007 Corcept Therapeutics Inc. Announces Phase 3 Study Evaluating CORLUX(R) for Psychotic Major Depression Misses Primary Endpoint
20 Mar 2007 Advanced Magnetics Completes Enrollment in Final Planned Phase III Study of Ferumoxytol as an IV Iron Replacement Therapeutic
19 Mar 2007 SEROQUEL(R) Sustained Release Schizophrenia Data presented at ECP Congress in Madrid
17 Mar 2007 Abeille Licenses AB-1001 to SymBio Pharmaceuticals for Commercialization in Japan and Pacific Rim Countries
17 Mar 2007 Amicus Therapeutics, Inc. Completes Phase 2 Enrollment of Amigal(TM) for Fabry Disease
17 Mar 2007 Exelixis Files IND Application for XL147
17 Mar 2007 Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
17 Mar 2007 Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
17 Mar 2007 Nippon Shinyaku and Teva terminate HMN-214 License Agreement
16 Mar 2007 Trimeris and Roche Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors
16 Mar 2007 Acura Pharmaceuticals, Inc. Updates OxyADF Tablets Development Program and Results of Study AP-ADF-102
16 Mar 2007 Eli Lilly Withdraws Its Marketing Authorization Application for Arxxant

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up